Agilon Health Stock to Reverse Split on Tuesday, March 31st (NYSE:AGL)

Agilon Health, Inc. (NYSE:AGLFree Report) shares are set to reverse split on Tuesday, March 31st. The 1-25 reverse split was announced on Wednesday, March 18th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, March 30th.

Agilon Health Stock Down 9.5%

Shares of NYSE AGL opened at $0.43 on Monday. Agilon Health has a one year low of $0.34 and a one year high of $6.08. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The business’s fifty day moving average price is $0.67 and its 200-day moving average price is $0.78. The stock has a market capitalization of $177.15 million, a PE ratio of -0.45 and a beta of 0.11.

Agilon Health (NYSE:AGLGet Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.19). Agilon Health had a negative return on equity of 120.82% and a negative net margin of 6.60%.The firm had revenue of $1.57 billion for the quarter, compared to the consensus estimate of $1.46 billion. On average, equities research analysts anticipate that Agilon Health will post -0.59 EPS for the current year.

Analysts Set New Price Targets

Several research firms have recently weighed in on AGL. Barclays reduced their target price on shares of Agilon Health from $1.00 to $0.50 and set an “underweight” rating for the company in a research note on Friday, February 27th. Wells Fargo & Company upped their price target on shares of Agilon Health from $1.00 to $1.50 and gave the company an “overweight” rating in a research note on Friday, February 27th. Royal Bank Of Canada raised shares of Agilon Health from a “hold” rating to a “moderate buy” rating in a report on Wednesday, December 3rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a research note on Wednesday, January 21st. Finally, Citigroup lowered their target price on shares of Agilon Health from $0.85 to $0.75 and set a “neutral” rating on the stock in a report on Tuesday, March 3rd. Three analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Agilon Health presently has an average rating of “Hold” and an average target price of $2.18.

Get Our Latest Stock Analysis on Agilon Health

Institutional Investors Weigh In On Agilon Health

Institutional investors and hedge funds have recently modified their holdings of the company. Goldman Sachs Group Inc. boosted its position in shares of Agilon Health by 196.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock valued at $13,812,000 after acquiring an additional 13,283,930 shares during the period. AQR Capital Management LLC lifted its stake in Agilon Health by 1,346.6% in the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock worth $7,033,000 after purchasing an additional 9,505,837 shares in the last quarter. CenterBook Partners LP lifted its stake in Agilon Health by 492.4% in the 3rd quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock worth $11,771,000 after purchasing an additional 9,499,012 shares in the last quarter. North Peak Capital Management LLC boosted its holdings in Agilon Health by 10.8% in the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after purchasing an additional 3,715,460 shares during the period. Finally, Voleon Capital Management LP grew its position in shares of Agilon Health by 5,519.2% during the 3rd quarter. Voleon Capital Management LP now owns 2,741,039 shares of the company’s stock valued at $2,823,000 after purchasing an additional 2,692,259 shares in the last quarter.

About Agilon Health

(Get Free Report)

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.

Read More

Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.